Jianming Xu

Jianming Xu is a gastrointestinal oncologist at Beijing Cancer Hospital who leads clinical trials examining adjuvant chemotherapy strategies including S-1 and CAPOX in resected gastric cancer adapted to Chinese patient populations. His research addresses high-volume gastric cancer management in China and contributes to Chinese national guidelines for gastric cancer. He participates in Asia-Pacific cooperative trials and has contributed to bridging East Asian gastric cancer trial data to Chinese clinical practice. Xu leads a multidisciplinary gastrointestinal oncology program at one of China's highest-volume cancer centers.